Invasive BC can be divided into different subtypes based on the expression of biomarkers, such as estrogen receptor (ER), progesterone receptor (PR), human epidermal growth factor receptor 2 (HER2) and Ki67 antigen [2, 5, 6]. This evidence concerns the gene ERBB2 and breast cancer.